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Abstract
Background: Antibiotic resistance is a problem in nursing homes. Presumed urinary tract infections (UTI) are the
most common infection. This study examines urine culture results from elderly patients to see if specific guidelines
based on gender or whether the patient resides in a nursing home (NH) are warranted.
Methods: This is a cross sectional observation study comparing urine cultures from NH patients with urine cultures
from patients in the same age group living in the community.
Results: There were 232 positive urine cultures in the NH group and 3554 in the community group. Escherichia coli
was isolated in 145 urines in the NH group (64 %) and 2275 (64 %) in the community group. There were no
clinically significant differences in resistance.
Combined, there were 3016 positive urine cultures from females and 770 from males. Escherichia coli was
significantly more common in females 2120 (70 %) than in males 303 (39 %)(p < 0.05). Enterococcus faecalis was
significantly less common in females 223(7 %) than males 137 (18 %) (p < 0.05). For females, there were lower
resistance rates to ciprofloxacin among Escherichia coli (7 % vs 12 %; p < 0.05) and to mecillinam among Proteus
mirabilis (3 % vs 12 %; p < 0.05).
Conclusions: Differences in resistance rates for patients in the nursing home do not warrant separate
recommendations for empiric antibiotic therapy, but recommendations based on gender seem warranted.
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Background
Antibiotic resistance is a worldwide problem threatening
our ability to treat infections [1]. Infections caused by
multi-resistant bacteria are increasing among the elderly
living in nursing homes (NH) [2–4]. The elderly are the
age group with the highest prevalence of antibiotic use in
Norway [5]. Anatomical and physiologic changes caused
by aging [6, 7], usage of urinary catheters, nasogastric and
percutaneous feeding tubes and intravenous catheters are
common in NH, all predisposing to bacterial colonization
and infections [8].
Urinary tract infections (UTI) are the most common
infections among NH patients [9, 10]. However, a con-
siderable proportion of antibiotic prescribing for pre-
sumed UTI is questionable. Treatment of asymptomatic
bacteriuria (ASB), and non-specific symptoms inaccur-
ately interpreted to be caused by UTIs is prevalent in
the NH despite no evidence of benefit and guidelines
dissuading this practice [11–14]. Inappropriate antibiotic
use is an important factor contributing to antibiotic re-
sistance [1]. It is therefore necessary to optimize anti-
biotic prescribing for UTI in the institutionalized elderly.
To accomplish this, knowledge of antibiotic resistance in
the NH is essential.
Studies from abroad indicate that the bacterial etiology
and resistance rates of UTI in NH patients resemble
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hospitalized patients more than they do the elderly living in
the community [15, 16]. Results from a recent Australian
study suggests that guidelines for empiric treatment of eld-
erly patients with UTI should take into consideration differ-
ences in antibiotic resistance patterns in bacteria causing
infections in the elderly living in NH versus the elderly liv-
ing at home [17]. However, antibiotic resistance varies
greatly between countries. Whether these findings are rele-
vant in Norway or other countries is unknown.
Several articles address differences in the prevalence
and microbiologic etiology of UTI in elderly women or
men, but separate therapy suggestions based on gender
are not specified [10, 18]. In addition, guidelines often
lack specific recommendations based on gender in the
elderly [19, 20].
We aim to assess whether the difference in resistance
rates of bacteria isolated from NH patients compared to
community dwelling elderly is so great that separate rec-
ommendations for empiric antibiotic therapy for UTI for
the two groups is necessary. Second, we aim to assess if
gender specific recommendations for antibiotic therapy
of UTI are warranted in the elderly.
Methods
Setting/patients
The laboratory for medical microbiology, Vestfold Hos-
pital Trust serves the population of Vestfold County
(240,000 inhabitants) [21]. NH patients resided in 34 dif-
ferent NHs in Vestfold County, were 65 years and older
with a positive urine culture in the time period from 16.
Nov 2009 through 31. Des 2010 (NH group). Results
were compared to all positive urine cultures from non-
hospitalized patients in Vestfold County 65 years or
older not living at a NH in the same time period, the
community dwelling group (CD). We registered both
microbes when two microbes with significant bacteriuria
were present.
Study design
The study is a cross-sectional observational study. The
microbiologic laboratory registers all urines received for
analysis and enters the patient’s full name, person num-
ber (unique for each person in Norway), address, the or-
dering physician and the institution (nursing home,
hospital, private practice, emergency call service, visiting
nurse service). In the CD group we excluded hospital-
ized patients, urines ordered by the visiting nurse service
and urines taken in the emergency room.
Microbiologic analysis and susceptibility testing
Urine cultures fulfilling the criteria for significant bacteri-
uria (≥10,000 colony-forming units/mL urine) were in-
cluded in the study. For Gram negative rods the automated
method Vitek 2 (bioMérieux) was used. Appropriate
antibiotics were selected for each bacterial species accord-
ing to recommendations from the Norwegian Working
Group on Antibiotics (NWGA) [22]. Results were inter-
preted according to clinical breakpoints from NWGA
which are based on those from The European Committee
on Antimicrobial Susceptibility Testing EUCAST [23]. Dip-
agar isolates and Gram positive bacteria were tested by disk
diffusion technique (Oxoid) after the manufacturer’s rec-
ommendations. Resistance values were recorded either as
susceptible (S), intermediate (I), or resistant (R).
Resistance data were extracted from the laboratory’s
database.
Norwegian guidelines for empiric therapy for UTI in the
nursing home [19]
Lower UTI: Pivmecillinam, trimethoprim, nitrofurantoin.
Upper UTI: Pivmecillinam, trimethoprim-
sulfamethoxazole, ciprofloxacin, ofloxacin.
Outcomes
1. Frequency and susceptibility of bacteria cultured in
urine specimens.
2. Susceptibility for each of the five most common
uropathogens: Escherichia coli (E coli), Klebsiella
pneumoniae (K pneumoniae), Proteus mirabilis (P
mirabilis), Enterococcus faecalis (E faecalis), and
Pseudomonas aeruginosa (P aeruginosa).
Calculating the theoretic risk of therapy failure
The theoretic risk of antibiotic failure depends on two
factors; the prevalence of the microbes in the patient
population and the resistance rate of these microbes to
the chosen antibiotic [24]. We calculated the theoretical
risk of therapy failure by multiplying the relative per-
centage each microbe was responsible for (e.g. for E coli
70.3 % for females and 39.4 % for males) with the resist-
ance rate for that antibiotic (e.g. ciprofloxacin for E col;
7.2 % for females and 11.9 % for males). We performed
these calculations for each of the five most commonly
isolated microbes; E coli, E faecalis, K pneumoniae, P
mirabilis, and P aeruginosa.
Statistical analysis
IBM SPSS® statistics program was used for statistical
analysis. We used a significance level of p < 0.05.
We used Pearson Chi2 test to compare differences in
gender distribution between the NH group and the CD
group and the t-test for independent samples to compare
the mean age in the two groups.
We used the Pearson Chi2 test and the Fischer’s exact test
(when appropriate) to compare differences in resistance
rates for relevant antibiotics between the NH group and
the CD group, and between males and females.
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Ethical considerations
The study has been approved by the Norwegian regional
ethics committee. The ethics committee waived the re-
quirement for informed consent for this study. (REK
sør-øst 2013/2282)
Results
There were 3786 bacteria isolates, 232 from NH patients
and 3554 from CD patients. Females contributed 183
(78.9 %) and 2833 (79.7 %) and males 49 (21.1 %) and
721 (20.3 %) of the isolates to the NH and CD groups
respectively (p =0.76).
The mean age of females in the NH group was 87.0
(SD 6.7; 95 % CI, 86.0-88.0) compared to 79.3 (SD 8.1;
95 % CI, 79.0-79.6) in the CD (p < 0.05). The mean age
for males in the NH group was 83.1 (SD 6.2; 95 % CI,
81.3-84.9) compared to 78.0 (SD 7.6; 95 % CI, 77.8-78.9)
in the CD group (p <0.05).
NH vs CD
There was no significant difference in the proportions of
any of the bacteria between patients in the NH group
and the CD group as a whole (Table 1). E coli was the
most common and E faecalis the next most common
pathogen isolated in both groups. In the category “Other
bacteria”, no single bacterium contributed more than
2.5 % to the total in either the NH or the CD group.
E coli resistance rates were over 20 % for both ampicillin
and trimethoprim in both groups (Table 2). The NH
group showed a slightly though non-significantly higher
resistance rate for ciprofloxacin than the CD group (9.5 vs
7.7 %). E faecalis resistance rates for trimethoprim were
over 20 % in both groups but exhibited no resistance to
ampicillin or nitrofurantoin in either group. K pneumo-
niae and P mirabilis resistance rates for ciprofloxacin were
significantly higher in the NH group (p < 0.05).
Male vs female (irrespective of residence)
The difference in the relative frequency of which bac-
teria were isolated between males and females was
highly significant (p < 0.05) (Table 1). For E coli there
was a significantly higher resistance rates for ciprofloxa-
cin for males than for females (p < 0.05). For P mirabilis
there was a significantly higher resistance rates for
mecillinam for males than for females (p < 0.05) (Table 3).
There were no significant differences in resistance rates
between males and females for E faecalis, K pneumoniae
or P aeruginosa.
Theoretic risk of empiric therapy failure
For females the risk of failure was greater than twenty
percent for ampicillin and trimethoprim. For males the
risk of failure was greater than twenty percent for ampi-
cillin, ciprofloxacin and mecillinam (Table 4).
Discussion
The differences between bacterial etiology and resistance
rates among uropathogens isolated from elderly patients
living in a NH and those living in the community were
clinically unimportant. There is however a significant and
clinically relevant difference between males and females
both in terms of bacterial etiology and resistance rates.
Therapy decisions in empiric antibiotic therapy are edu-
cated guesses based on the relative prevalence of the mi-
crobes causing the infection and the resistance rates of
these microbes. Guidelines for empiric antibiotic therapy
consider both these factors and the severity of the infec-
tion. The sum of potentially inadequate coverage (e.g.
mecillinam for P aeruginosa) or high resistance rates for a
specific antibiotic (e.g. ampicillin for E coli) will influence
recommendations for empiric therapy. Previous studies of
urinary tract isolates from hospitalized patients with py-
elonephritis and out-patients with uncomplicated UTI
Table 1 Urine culture results from patients living in a nursing home (NH) compared to community dwelling elderly (CD) in Vestfold
County, Norway 2010
E coli E faecalis K pneumoniae P mirabilis P aeruginosa Othera
NH Female n (%) 133 (72.7) 11 (6.0) 5 (2.7) 8 (4.4) 4 (2.2) 22 (12.0)
Male n (%) 15 (30.6) 8 (16.3) 6 (12.2) 4 (8.2) 2 (4.1) 14 (28.6)
p-value < 0.01b 0.47 0.28 0.61 0.55 0.21
CD Female n (%) 1987 (70.1) 212 (7.5) 165 (5.8) 93 (3.3) 32 (1.1) 344 (12.1)
Male n (%) 288 (39.9) 129 (17.9) 43 (6.0) 38 (5.3) 25 (3.5) 198 (27.5)
p-value < 0.01c < 0.01c 0.96 0.59 0.54 < 0.01c
NH n (%) 148 (63.8) 19 (8.2) 11 (4.7) 12 (5.2) 6 (2.6) 36 (15.5)
CD n (%) 2275 (64.0) 341 (9.6) 208 (5.9) 131 (3.7) 57 (1.6) 542 (15.3)
Total n 2423 360 219 143 63 578
p-value 0.48 0.42 0.43 0.6 0.86 0.49
aOther was comprised of 18 different microbes in the NH group and 24 different microbes in the CD group
bComparison between females and males in the NH > 65 years old
cComparison between CD females and males > 65 years old
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have shown that guidelines may need updating to be in
concordance with local susceptibility rates [25–27].
Studies indicate increased bacterial resistance in bac-
teria causing UTI in the elderly living in health care fa-
cilities than in community acquired UTI and is similar
to hospital acquired UTI [10, 15]. A recent Australian
study suggested changes in empiric therapy recommen-
dations for UTI due to higher resistance rates among
Enterobacteriacea (E coli, K pneumoniae and P mir-
abilis) isolated in urine cultures from NH patients than
in community dwelling elderly [17]. Our study also
showed a higher rate of resistance for Enterobacteriacea
in urine cultures from NH patients but comes to a dif-
ferent conclusion. The non-significantly higher rate of
ciprofloxacin resistance in E coli from nursing home pa-
tients is far below the 20 % resistance rate normally used
to dissuade the choice in empiric treatment for non-
serious infections like cystitis. Because K pneumoniae and
P mirabilis contribute minimally to the total number of
UTI they do not result in a significantly higher risk of
therapy failure in the NH despite the higher rates of resist-
ance in these bacteria. Consequently, differences between
culture results from the NH and the elderly living in the
community do not warrant separate recommendations for
empiric antibiotic therapy for cystitis.
Our results do, however, indicate that separate rec-
ommendations may be in order for males and females
irrespective of where the patient resides. This is not
surprising as the bacterial etiology of UTI differs be-
tween males and females, a finding reflected in other
studies [10, 28]. Ciprofloxacin and mecillinam may be
poor choices for empiric treatment for males due to a
higher rate of ciprofloxacin resistance among E coli
and a relatively high prevalence of E faecalis for
which neither ciprofloxacin nor mecillinam are rec-
ommended. The higher prevalence of E faecalis in the
Table 2 Resistance rates of the five most commonly isolated uropathogens from patients living in nursing homes (NH) compared to
community dwelling elderly (CD) in Vestfold County, Norway 2010
E coli E faecalisa K pneumoniae P mirabilis P aeruginosa
NH CD NH CD NH CD NH CD NH CD
n (%) n (%) p-value n (%) n (%) p-value n (%) n (%) p-value n (%) n (%) p-value n (%) n (%) p-value
Ampicillinb 48 (32) 732 (32) 0.95 0 0 Resc Res 2 (17) 14 (11) 0.63 Res Res
Ciprofloxacind 14 (10) 175 (8) 0.08 NAe NAe 2 (18) 7 (3) 0.07 3 (25) 7 (5) 0.04h 0 (0) 5 (9) 0.6
Mecillinam 4 (3) 83 (3.6) 0.82 NAf NAf 1 (9) 16 (8) 0.62 1 (8) 6 (5) 0.51 Res Res
Nitrofurantoin 3 (2) 39 (2) 0.76 0 0 Res Res Res Res Res Res
Trimethoprimg 36 (24) 513 (23) 0.1 6 (32) 93 (27) 0.69 1 (9) 39 (19) 0.46 3 (25) 23 (18) 0.79 Res Res
aResistance rate for Vancomycin was 0 % in both groups
bFor E coli, and P mirabilis intermediate (I) is classified as sensitive (S) according to recommendations from Norwegian Working Group on Antibiotics
cRes: Resistant
d(S) classified as (I) if the microbe in question is resistant (R) for nalidixic acid
eNA: not applicable. Minimum inhibitory concentrations are so high that ciprofloxacin is not recommended for infections due to E Faecalis
fNA: not applicable. Mecillinam is ineffective against E Faecalis in vitro
gFor E faecalis intermediate (I) is classified as sensitive (S)
hSignificant at α = 5 %
Table 3 Resistance rates of the five most commonly isolated uropathogens from patients 65 years old or older in Vestfold County,
Norway 2010: females compared to males (irrespective of residence)
E coli E faecalisa K pneumoniae P mirabilis P aeruginosa
NH CD NH CD NH CD NH CD NH CD
n (%) n (%) p-value n (%) n (%) p-value n (%) n (%) p-value n (%) n (%) p-value n (%) n (%) p-value
Ampicillinb 680 (32) 100 (33) 0.74 0 0 Resc Res 11 (11) 5 (12) 0.99 Res Res
Ciprofloxacind 153 (7) 36 (12) 0.03h NAe NAe 5 (3) 4 (8) 0.12 8 (8) 2 (5) 0.72 4 (11) 1 (4) 0.38
Mecillinam 74 (4) 13 (4) 0.51 NAf NAf 13 (8) 4 (8) 0.32 2 (2) 5 (12) 0.02h Res Res
Nitrofurantoin 39 (2) 3 (1) 0.54 0 0 Res Res Res Res Res Res
Trimethoprimg 490 (23) 59 (20) 0.36 65 (29) 34 (25) 0.1 27 (16) 13 (27) 0.1 22 (22) 4 (10) 0.4 Res Res
aResistance rate for Vancomycin was 0 % in both groups
bFor E coli, and P mirabilis intermediate (I) is classified as sensitive (S) according to recommendations from Norwegian Working Group on Antibiotics
cRes: Resistant
d(S) classified as (I) if the microbe in question is resistant (R) for nalidixic acid
eNA: not applicable. Minimum inhibitory concentrations are so high that ciprofloxacin is not recommended for infections due to E Faecalis
fNA: not applicable. Mecillinam is ineffective against E Faecalis in vitro
gFor E faecalis intermediate (I) is classified as sensitive (S)
hSignificant at α = 5 %
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elderly male population is a finding seen in other
studies also [28, 29]. In addition, there are higher
rates of mecillinam resistance among K pneumoniae
and P mirabilis in males vs females. These results
should be interpreted cautiously due to the uncer-
tainty of catheter status. In the NH, use of permanent
urinary catheters is more prevalent in males than in
females [30]. Furthermore, bacteria from patients with
urinary catheters have a higher rate of resistant or-
ganisms [31–33].
Trimethoprim may be a poor choice for females but
acceptable in males due to the higher rate of E coli
resistance in females than in males. Amoxicillin can-
not be recommended for empiric therapy for either
gender. Treatment of UTI should also take into con-
sideration that even relatively high doses of trimetho-
prim or nitrofurantoin will not give high enough
serum or tissue levels to result in cure for pyeloneph-
ritis or prostatitis infections especially if the infection
is caused by E coli or other Enterobacteriacea species.
The rates of resistance shown in our study are similar
to national surveillance rates in Norway, but are some-
what higher than a recent study of a NH in Sweden rais-
ing a question of the external validity of our study [31,
34]. A possible explanation for this is that our isolates
were from patients having infections which were to be
treated while the Swedish study examined urine from all
patients able to provide a urine sample. This could po-
tentially make the contribution of ASB higher in the
Swedish study.
The concept of external validity is relevant when it
comes to studies dealing with empiric antibiotic treat-
ment because resistance problems vary substantially
throughout the world. The theoretic model presented
in Table 4 is based on local resistance patterns mak-
ing the issue of its external validity salient. While the
results here do not have relevance in other countries,
the theoretic basis behind determining the risk of
treatment failure is relevant anywhere by using local
resistance data [24].
Earlier studies from Norway show lower resistance
rates than in this study [35]. This change over time and
the differences between the Swedish, Australian and our
study illustrate the need for periodic national monitoring
of resistance development to keep guideline recommen-
dations up to date and reliable. Reliable guidelines are
an important part of antibiotic stewardship but there are
numerous barriers impairing adherence to guidelines
[36, 37]. Lack of periodic surveillance can undermine
the credibility of empiric therapy guidelines, and worse,
result in therapy failure for patients.
There are several weaknesses in our study. We are un-
certain about the compliance with the Norwegian guide-
lines outlining correct urine sampling technique in the
two groups [38]. Urinary incontinence makes correct
urine sampling challenging and is more prevalent in the
NH than in the community [39]. Urinary catheter status
was not reported systematically in either the NH group
or the CD group making conclusions about the contri-
bution of catheter associated infections impossible. Rates
of inappropriate collection techniques and the preva-
lence of cultures from catheterized patients may be dif-
ferent in the two groups. Given this potential selection
bias one might expect a higher rate of resistance and
higher prevalence of pathogenic bacteria in the NH, but
the results in our study show no such difference.
In the NH group, all culture results were from patients
with suspected UTI treated with antibiotics. None of the
NH urines were due to post-therapy control. Norwegian
guidelines dissuade urine culturing for ASB and do not
recommend routine post-therapy control [19]. Despite
this, the CD group may be less homogeneous because
we cannot ascertain the proportion of the culture results
due to UTI, ASB or the contribution of post-therapy
control cultures. In addition, the relative contribution of
lower UTI and upper UTI in the two groups is not pre-
cisely known. As the incidence of dementia, use of cath-
eters and urinary incontinence are higher in the NH
setting one would expect the rate of complicated UVI
inclusive pyelonephritis to be higher in this group [40].
Patients in the NH group were on average 10 years
older than the CDs. Antibiotic resistance among uro-
pathogens in general and for ciprofloxacin specifically is
higher in the elderly [16, 40–42]. In this case having a
younger CD group would contribute to making the dif-
ference in resistance rates between the two groups more
obvious. That was not the case in this study.
Conclusion
In Norway, differences in resistance rates for patients 65
years and older living at home or in a nursing home do
not warrant separate recommendations for empiric anti-
biotic therapy but recommendations based on gender
seem warranted.
Table 4 Theoretic risk of failure with empiric antibiotic therapy
(%) due to resistance rates in urine cultures from elderly
patients (both NH and CD) in Vestfold County Norway 2010a
Empiric antibiotic Female Male
Ampicillin 29.7 23.6
Ciprofloxacin 13.0 23.4
Mecillinam 11.5 24.2
Nitrofurantoin 11.4 15.9
Trimethoprim 21.2 17.8
aBased on the five most commonly cultured bacteria; E coli, E faecalis, K
pneumoniae, P mirabilis, and P aeruginosa. The percentages are calculated by
multiplying the percentage each microbe was responsible for by the
resistance rate for that microbe
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